Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13752
Title: Australian patterns of prostate cancer care: Are they evolving?
Authors: Lo, J;Papa, Nathan P;Bolton, Damien M;Murphy, Declan;Lawrentschuk, Nathan L
Issue Date: Mar-2016
EDate: 2015-12-15
Citation: Prostate international 2016, vol. 4(1) p. 20-4
Abstract: BACKGROUND: Approaches to prostate cancer (PCa) care have changed in recent years out of concern for overdiagnosis and overtreatment. Despite these changes, many patients continue to undergo some form of curative treatment and with a growing perception among multidisciplinary clinicians that more aggressive treatments are being favored. This study examines patterns of PCa care in Australia, focusing on current rates of screening and aggressive interventions that consist of high-dose-rate (HDR) brachytherapy and pelvic lymph node dissection (PLND). METHODS: Health services data were used to assess Australian men undergoing PCa screening and treatment from 2001 to 2014. Age-specific rates of prostate-specific antigen (PSA) screening were calculated. Ratios of radical prostatectomy (RP) with PLND to RP without PLND, and HDR brachytherapy to low-dose-rate (LDR) brachytherapy were determined by state jurisdictions. RESULTS: From 2008, the rate of PSA screening trended downward significantly with year for all age ranges (P < 0.02) except men aged ≥ 85 (P = 0.56). PLND rates for 2008-2014 were lower than rates for 2001-2007 across all states and territories. From 2008 to 2014, PLND was performed ≥ 2.7 times more frequently in New South Wales and the Australian Capital Territory than in other jurisdictions. Since 2007, brachytherapy practice across Australia has evolved towards a relatively low use of HDR brachytherapy (ratio of HDR to LDR brachytherapy < 0.5 for all jurisdictions except the Australian Capital Territory). CONCLUSION: Rates of PLND and HDR brachytherapy for PCa have declined in Australia, providing evidence for the effect of stage migration due to widespread PSA screening. Currently, PSA screening rates remain high among older men, which may expose them to unnecessary investigations and treatment-related morbidity.
URI: http://ahro.austin.org.au/austinjspui/handle/1/13752
DOI: 10.1016/j.prnil.2015.11.001
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/27014660
Type: Journal Article
Subjects: Brachytherapy
Prostatectomy
Prostatic Neoplasms
Mass Screening
Lymph Node Excision
Type of Clinical Study or Trial: Reviews/Systematic Reviews
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.